Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

Roche shares slip as profits miss expectations

Roche shares slip as profits miss expectations and Perjeta (pertuzumab) - which collectively grew 19% to CHF 8.76bn.

Roche's Kadcyla fails in gastric cancer trial

Roche's Kadcyla fails in gastric cancer trial Among its best-performing products were breast cancer therapy Perjeta (pertuzumab), up 66% to CHF 1.04bn in the nine-month period, and this in turn helped boost sales of Herceptin

Roche's Perjeta launches in UK for early breast cancer

Roche's Perjeta launches in UK for early breast cancer Roche's Perjeta is now licensed for use in the UK as a treatment for early-stage breast cancer, a few weeks after the new indication was approved in Europe. ... Perjeta was already approved to treat previously-untreated advanced HER2-positive breast

European approval for Roche’s next-gen breast cancer drug

European approval for Roche’s next-gen breast cancer drug Perjeta now available in EU for use before surgery in early stage aggressive breast cancer.  . ... We are committed to making the Perjeta regimen available to appropriate patients in the EU as early as possible.”.

UK pharma rebate payment doubles in one year

UK pharma rebate payment doubles in one year First quarter repayment £138m higher than this time last year

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics